Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

(Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice

  • Dien Ye
  • , Xiaofei Yang
  • , Liwei Ren
  • , Hong S. Lu
  • , Yuan Sun
  • , Hui Lin
  • , Lunbo Tan
  • , Na Wang
  • , Genevieve Nguyen
  • , Michael Bader
  • , Adam E. Mullick
  • , A. H.Jan Danser
  • , Alan Daugherty
  • , Yizhou Jiang
  • , Yidan Sun
  • , Furong Li
  • , Xifeng Lu

Producción científica: Articlerevisión exhaustiva

5 Citas (Scopus)

Resumen

Objective: Elevated plasma cholesterol concentrations contributes to ischemic cardiovascular diseases. Recently, we showed that inhibiting hepatic (pro)renin receptor [(P)RR] attenuated diet-induced hypercholesterolemia and hypertriglyceridemia in low-density lipoprotein receptor (LDLR) deficient mice. The purpose of this study was to determine whether inhibiting hepatic (P)RR could attenuate atherosclerosis. Approach and Results: Eight-week-old male LDLR−/− mice were injected with either saline or N-acetylgalactosamine-modified antisense oligonucleotides (G-ASOs) primarily targeting hepatic (P)RR and were fed a western-type diet (WTD) for 16 weeks. (P)RR G-ASOs markedly reduced plasma cholesterol concentrations from 2,211 ± 146 to 1,128 ± 121 mg/dL. Fast protein liquid chromatography (FPLC) analyses revealed that cholesterol in very low-density lipoprotein (VLDL) and intermediate density lipoprotein (IDL)/LDL fraction were potently reduced by (P)RR G-ASOs. Moreover, (P)RR G-ASOs reduced plasma triglyceride concentrations by more than 80%. Strikingly, despite marked reduction in plasma lipid concentrations, atherosclerosis was not reduced but rather increased in these mice. Further testing in ApoE−/− mice confirmed that (P)RR G-ASOs reduced plasma lipid concentrations but not atherosclerosis. Transcriptomic analysis of the aortas revealed that (P)RR G-ASOs induced the expression of the genes involved in immune responses and inflammation. Further investigation revealed that (P)RR G-ASOs also inhibited (P)RR in macrophages and in enhanced inflammatory responses to exogenous stimuli. Moreover, deleting the (P)RR in macrophages resulted in accelerated atherosclerosis in WTD fed ApoE−/− mice. Conclusion: (P)RR G-ASOs reduced the plasma lipids in atherosclerotic mice due to hepatic (P)RR deficiency. However, augmented pro-inflammatory responses in macrophages due to (P)RR downregulation counteracted the beneficial effects of lowered plasma lipid concentrations on atherosclerosis. Our study demonstrated that hepatic (P)RR and macrophage (P)RR played a counteracting role in atherosclerosis.

Idioma originalEnglish
Número de artículo725203
PublicaciónFrontiers in Cardiovascular Medicine
Volumen8
DOI
EstadoPublished - 2021

Nota bibliográfica

Publisher Copyright:
Copyright © 2021 Ye, Yang, Ren, Lu, Sun, Lin, Tan, Wang, Nguyen, Bader, Mullick, Danser, Daugherty, Jiang, Sun, Li and Lu.

Financiación

The author XL is supported by National Natural Science Foundation of China (81870605), Shenzhen Municipal Science and Technology Innovation Council (JCYJ20190808170401660), and Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis (ZDSYS20190902092903237). YuS is supported by National Natural Science Foundation of China (81800383). FL is supported by National Natural Science Foundation of China (81670702), and Shenzhen Municipal Science and Technology Innovation Council (GJHZ20170310090257380). AHJD is supported by the Top Institute Pharma (T2-301). YiS is supported by Guangdong Basic and Applied Basic Research Foundation (2019A1515110993). YJ is supported by Shenzhen Municipal Science and Technology Innovation Council (Grant No. JCYJ20180305124812444).

FinanciadoresNúmero del financiador
Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis81800383, GJHZ20170310090257380, 81670702, ZDSYS20190902092903237
National Natural Science Foundation of China (NSFC)81870605
National Natural Science Foundation of China (NSFC)
Top Institute PharmaT2-301
Top Institute Pharma
Shenzhen Municipal Science and Technology Innovation CouncilJCYJ20190808170401660
Shenzhen Municipal Science and Technology Innovation Council
Basic and Applied Basic Research Foundation of Guangdong ProvinceJCYJ20180305124812444, 2019A1515110993
Basic and Applied Basic Research Foundation of Guangdong Province

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Huella

    Profundice en los temas de investigación de '(Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice'. En conjunto forman una huella única.

    Citar esto